跳至主要内容
临床试验/NCT06022419
NCT06022419招募中不适用

Conservative Therapy of Proximal Phalanx Fractures - a Prospective Randomized Study Comparing the Lucerne Cast With Finger Splinting

Medical University of Vienna2 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2023年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
86
试验地点
2
主要终点
Brief Michigan-Hand-Outcome-Questionnaire

研究概览

简要总结

The purpose of this prospective randomized controlled clinical trial is to evaluate if the lucerne cast leads to a better functional outcome than a forearm cast with a finger splint in patients with a proximal phalanx fracture.

详细描述

This study represents a prospective randomized controlled clinical trial comparing two different conservative treatment options in patients with proximal phalanx fractures.

Patients meeting the inclusion criteria will be enrolled in the present study provided they give their consent. Informed written consent will be obtained. Randomization will be performed according to the CONSORT Guidelines of Prospective Randomized Trials using the software "Randomizer" by the Medical University of Graz. Patients allocated to the control group will receive a forearm cast with a finger splint, while patients in the study group will receive the lucerne cast. Both groups will receive the allocated cast for 4 weeks. Clinical outcome will be assessed 12 weeks after trauma.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Proximal phalanx fracture in the fingers (II - V)
  • Patient age between 18 and 70 years

排除标准

  • Condylar fracture
  • Avulsions of the collateral ligament
  • Pathologic fracture
  • Intraarticular fracture
  • Patients unable to consent
  • Polytraumatized patients
  • Patients initially presenting more than 7 days after injury
  • Pregnancy
  • Compound fractures
  • Multiple hand injuries

结局指标

主要结局

Brief Michigan-Hand-Outcome-Questionnaire

时间窗: at 12 weeks

patient-based standardised questionnaire (12 items, range 0-100, 100=ideal function, 0=poorest function)

次要结局

  • Treatment Failure(at 1, 2, 4 and 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Paul L Hoppe

M.D.

Medical University of Vienna

研究点 (2)

Loading locations...

相似试验